Flerie (FLERIE.ST)

Flerie stock price today, ATLAS forecast and fair value

Healthcare · Biotechnology · Nasdaq Stockholm · Sweden

SEK 14.80▼ -0.67%

Prices as of Oct 27, 2026 · SEK

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

51%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Flerie in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Flerie

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives Flerie a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between SEK 14.06 and SEK 15.63; in 9 out of 10, between SEK 12.80 and SEK 17.17. Estimated annual volatility is 30%.

Price, last 12 months (weekly close)

Key numbers

Market cap: SEK 1.4B
Market cap (USD): $137M
52-week high: SEK 40.95
52-week low: SEK 14.45
Revenue (12 months): SEK 2.6M
Net margin: 0.0%
Beta: -0.33

What this means

ATLAS does not publish a fair value for FLERIE.ST right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks FLERIE.ST has traded between SEK 14.45 and SEK 40.95. Today it is 63.9% below that high and 2% above its low.

Its beta is -0.33: it tends to move less than the market.

About the company

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time.

Want to see everything about Flerie?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What does Flerie do?

What is the chance FLERIE.ST goes up next month?

51%: close to a coin flip. In half of the simulated outcomes, FLERIE.ST ends the month between SEK 14.06 and SEK 15.63.

How big is Flerie and what is its P/E ratio?

Flerie's market capitalization is SEK 1.4B. We do not show a P/E because it has no positive earnings to base one on.

How volatile is FLERIE.ST?

ATLAS estimates annual volatility at 30%. In a typical month, half of the outcomes end between SEK 14.06 and SEK 15.63.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer